Canadian pricing review board enters into four compliance agreements in 1994.
CANADIAN PRICING REVIEW BOARD ACCEPTED FOUR COMPLIANCE AGREEMENTS IN 1994, bringing the total number of voluntary compliance undertakings between pharmaceutical firms and the Canadian Patented Medicine Prices Review Board to 10. The four VCUs cover eight drug products. The agreements "involved price reductions and measures to offset excess revenues of $4.3 mil. including payments of $3.6 mil. to the Government of Canada," the January 1995 PMPRB "Bulletin" states. The PMPRB was established in December 1987 to regulate the prices of patented medicines. The first VCU action was in 1993.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth